2016年脓毒症与脓毒性休克共识定义对未来脓毒症研究的潜在影响
该研究是对ARISE试验的事后分析,纳入1,591例急诊科早期脓毒性休克成人患者(符合≥2条全身炎症反应综合征标准且存在难治性低血压或高乳酸血症)。分析显示,基线时1,139例(71.6%)qSOFA评分≥2分,1,347例(84.7%)符合Sepsis-3脓毒症定义,仅1,010例(63.5%)同时qSOFA阳性且符合Sepsis-3脓毒症定义;203例(12.8%)符合Sepsis-3脓毒性休克定义。符合Sepsis-3脓毒症和脓毒性休克定义者的90天死亡率分别为20.4%和29.6%,均高于不符合者。作者认为,qSOFA作为急诊科疑似感染患者脓毒症试验筛查工具的效用可能有限。
要点
- ARISE试验1,591例急诊早期脓毒性休克患者中,仅203例(12.8%)在基线符合Sepsis-3脓毒性休克定义,其中175例(86.2%)qSOFA阳性。
- 1,347例(84.7%)符合Sepsis-3脓毒症定义,但仅1,010例(63.5%)同时qSOFA阳性且符合Sepsis-3脓毒症定义,即部分符合Sepsis-3脓毒症定义者qSOFA筛查阴性。
- 符合Sepsis-3脓毒症定义者90天死亡率为20.4%(274/1,344),不符合者为9.4%(23/244),风险差11.0%(95%CI 6.2%至14.8%)。
- 符合Sepsis-3脓毒性休克定义者90天死亡率为29.6%(60/203),不符合者为17.1%(237/1,388),风险差12.5%(95%CI 6.3%至19.4%)。
- 作者认为,qSOFA作为急诊科疑似感染患者脓毒症试验筛查工具的效用可能有限。
适用人群与场景
- ARISE试验纳入的成人患者,就诊于急诊科,诊断为早期脓毒性休克,诊断依据为符合≥2条全身炎症反应综合征标准且存在难治性低血压或高乳酸血症。
- 本研究为对ARISE试验入组患者的事后分析。
诊断标准与关键阈值
- Sepsis-3脓毒症定义:因感染导致序贯器官衰竭评估评分增加≥2分。
- qSOFA评分≥2分为筛查阳性。
研究设计与关键结果
- 研究类型:对ARISE试验(早期目标导向治疗试验)的事后分析;样本量1,591例成人急诊早期脓毒性休克患者。
- 基线qSOFA评分≥2分者1,139例(71.6%,95%CI 69.4%至73.8%)。
- 符合Sepsis-3脓毒症定义者1,347例(84.7%,95%CI 82.9%至86.4%);同时qSOFA阳性且符合Sepsis-3脓毒症定义者1,010例(63.5%,95%CI 61.1%至65.8%)。
- 符合Sepsis-3脓毒性休克定义者203例(12.8%,95%CI 11.2%至14.5%),其中qSOFA阳性者175例(86.2%,95%CI 81.5%至91.0%)。
- 符合Sepsis-3脓毒症定义者90天死亡率为20.4%(95%CI 18.2%至22.5%)(274/1,344),不符合者为9.4%(95%CI 5.8%至13.1%)(23/244),风险差11.0%(95%CI 6.2%至14.8%)。
- 符合Sepsis-3脓毒性休克定义者90天死亡率为29.6%(95%CI 23.3%至35.8%)(60/203),不符合者为17.1%(95%CI 15.1%至19.1%)(237/1,388),风险差12.5%(95%CI 6.3%至19.4%)。
证据类型、等级与局限
- 证据类型:对ARISE随机对照试验的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,qSOFA作为急诊科疑似感染患者脓毒症试验筛查工具的效用可能有限,因为部分符合Sepsis-3脓毒症定义者qSOFA筛查阴性。
- 多数ARISE试验入组的早期脓毒性休克患者不符合Sepsis-3脓毒性休克定义,这对未来脓毒症试验的入组标准选择有潜在影响。
- 新定义对不符合ARISE试验入组条件的患者的影响尚不清楚。
指南或共识出处
- 本文为对ARISE试验的事后分析,非指南或共识文件。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: The influence of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) on the conduct of future sepsis research is unknown. We seek to examine the potential effect of the new definitions on the identification and outcomes of patients enrolled in a sepsis trial.
METHODS: This was a post hoc analysis of the Australasian Resuscitation in Sepsis Evaluation (ARISE) trial of early goal-directed therapy that recruited 1,591 adult patients presenting to the emergency department (ED) with early septic shock diagnosed by greater than or equal to 2 systemic inflammatory response syndrome criteria and either refractory hypotension or hyperlactatemia. The proportion of participants who would have met the Sepsis-3 criteria for quick Sequential Organ Failure Assessment (qSOFA) score, sepsis (an increased Sequential Organ Failure Assessment score ≥2 because of infection) and septic shock before randomization, their baseline characteristics, interventions delivered, and mortality were determined.
RESULTS: There were 1,139 participants who had a qSOFA score of greater than or equal to 2 at baseline (71.6% [95% confidence interval {CI} 69.4% to 73.8%]). In contrast, 1,347 participants (84.7% [95% CI 82.9% to 86.4%]) met the Sepsis-3 criteria for sepsis. Only 1,010 participants were both qSOFA positive and met the Sepsis-3 criteria for sepsis (63.5% [95% CI 61.1% to 65.8%]). The Sepsis-3 definition for septic shock was met at baseline by 203 participants (12.8% [95% CI 11.2% to 14.5%]), of whom 175 (86.2% [95% CI 81.5% to 91.0%]) were also qSOFA positive. Ninety-day mortality for participants fulfilling the Sepsis-3 criteria for sepsis and septic shock was 20.4% (95% CI 18.2% to 22.5%) (274/1,344) and 29.6% (95% CI 23.3% to 35.8% [60/203]) versus 9.4% (95% CI 5.8% to 13.1%) (23/244) and 17.1% (95% CI 15.1% to 19.1% [237/1,388]), respectively, for participants not meeting the criteria (risk differences 11.0% [95% CI 6.2% to 14.8%] and 12.5% [95% CI 6.3% to 19.4%], respectively).
CONCLUSION: Most ARISE participants did not meet the Sepsis-3 definition for septic shock at baseline. However, the majority fulfilled the new sepsis definition and mortality was higher than for participants not fulfilling the criteria. A quarter of participants meeting the new sepsis definition did not fulfill the qSOFA screening criteria, potentially limiting its utility as a screening tool for sepsis trials with patients with suspected infection in the ED. The implications of the new definitions for patients not eligible for recruitment into the ARISE trial are unknown.
参考来源
- Peake SL, Delaney A, Bailey M, et al. Potential Impact of the 2016 Consensus Definitions of Sepsis and Septic Shock on Future Sepsis Research. Ann Emerg Med. 2017. PMID: 28601273. doi:10.1016/j.annemergmed.2017.04.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。